{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T23:34:57Z","timestamp":1781134497286,"version":"3.54.1"},"reference-count":32,"publisher":"American Society for Microbiology","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2018,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Yellow fever (YF) is a reemerging public health threat, with frequent outbreaks prompting large vaccination campaigns in regions of endemicity in Africa and South America. Specific detection of vaccine-related adverse events is resource-intensive, time-consuming, and difficult to achieve during an outbreak. To address this, we have developed a highly transferable rapid yellow fever virus (YFV) vaccine-specific real-time reverse transcription-PCR (RT-PCR) assay that distinguishes vaccine from wild-type lineages. The assay utilizes a specific hydrolysis probe that includes locked nucleic acids to enhance specific discrimination of the YFV17D vaccine strain genome. Promisingly, sensitivity and specificity analyses reveal this assay to be highly specific to vaccine strain(s) when tested on clinical samples and YFV cell culture isolates of global origin. Taken together, our data suggest the utility of this assay for use in laboratories of varied capacity for the identification and differentiation of vaccine-related adverse events from wild-type infections of both African and South American origin.<\/jats:p>","DOI":"10.1128\/jcm.00323-18","type":"journal-article","created":{"date-parts":[[2018,4,9]],"date-time":"2018-04-09T11:09:24Z","timestamp":1523272164000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":15,"title":["Development of a Real-Time Reverse Transcription-PCR Assay for Global Differentiation of Yellow Fever Virus Vaccine-Related Adverse Events from Natural Infections"],"prefix":"10.1128","volume":"56","author":[{"given":"Holly R.","family":"Hughes","sequence":"first","affiliation":[{"name":"Centers for Disease Control and Prevention, Fort Collins, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandy J.","family":"Russell","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Fort Collins, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric C.","family":"Mossel","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Fort Collins, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kayiwa","sequence":"additional","affiliation":[{"name":"Uganda Virus Research Institute, Entebbe, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julius","family":"Lutwama","sequence":"additional","affiliation":[{"name":"Uganda Virus Research Institute, Entebbe, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy J.","family":"Lambert","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Fort Collins, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2014.08.030"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.53.1.7"},{"key":"e_1_3_3_4_2","first-page":"77","article-title":"The yellow fever vaccine: a history","volume":"83","author":"Frierson JG","year":"2010","unstructured":"Frierson JG. 2010. The yellow fever vaccine: a history. Yale J Biol Med 83:77\u201385.","journal-title":"Yale J Biol Med"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.65.6.787"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.65.6.767"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1022700"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)05327-2"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)05326-0"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taw045"},{"key":"e_1_3_3_11_2","volume-title":"Division of Emerging and other Communicable Diseases, Surveillance and Control","author":"WHO","year":"1998","unstructured":"WHO. 1998. District guidelines for yellow fever surveillance. Division of Emerging and other Communicable Diseases, Surveillance and Control, World Health Organization, Geneva, Switzerland. http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/64384\/www9834.pdf?sequence=1."},{"key":"e_1_3_3_12_2","volume-title":"Yellow fever situation report: 28 October 2016","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. 2016. Yellow fever situation report: 28 October 2016. World Health Organization, Geneva, Switzerland. http:\/\/www.who.int\/emergencies\/yellow-fever\/situation-reports\/28-october-2016\/en\/."},{"key":"e_1_3_3_13_2","volume-title":"Detection and investigation of serious adverse events following yellow fever vaccination: guidance from an informal consultation of experts, 18\u201319 November 2008, Geneva, Switzerland","author":"World Health Organization","year":"2008","unstructured":"World Health Organization. 2008. Detection and investigation of serious adverse events following yellow fever vaccination: guidance from an informal consultation of experts, 18\u201319 November 2008, Geneva, Switzerland. World Health Organization, Geneva, Switzerland. http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/70251\/WHO_HSE_GAR_ERI_2010.2_eng.pdf?sequence=1."},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2311.171131"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.7.2019"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi060307w"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1081\/NCN-100002312"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkl175"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gnh046"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2013.11.002"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1586\/14737159.3.1.27"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2003.09.003"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0143444"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12917-014-0225-4"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2011.442"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/molbev\/msw054"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01799-12"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygeno.2007.10.016"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi035976d"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi200904e"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.12.057"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit546"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2010.04.013"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.00323-18","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.00323-18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T09:03:02Z","timestamp":1646470982000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.00323-18"}},"subtitle":[],"editor":[{"given":"Angela M.","family":"Caliendo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["10.1128\/JCM.00323-18"],"URL":"https:\/\/doi.org\/10.1128\/jcm.00323-18","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"2018-02-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-04-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-05-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00323-18"}}